Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 7 studies | 21% ± 7% | |
| epithelial cell | 6 studies | 30% ± 14% | |
| basal cell | 6 studies | 27% ± 11% | |
| goblet cell | 5 studies | 23% ± 8% | |
| squamous epithelial cell | 4 studies | 39% ± 17% | |
| brush cell | 4 studies | 39% ± 17% | |
| myeloid cell | 3 studies | 32% ± 23% | |
| secretory cell | 3 studies | 20% ± 4% | |
| macrophage | 3 studies | 29% ± 12% | |
| enteroendocrine cell | 3 studies | 22% ± 3% | |
| alveolar macrophage | 3 studies | 25% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 3 studies | 23% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 99% | 1295.69 | 325 / 328 | 96% | 61.61 | 170 / 178 |
| lung | 88% | 1008.54 | 507 / 578 | 95% | 49.97 | 1101 / 1155 |
| thymus | 99% | 1964.55 | 648 / 653 | 82% | 31.03 | 496 / 605 |
| stomach | 75% | 1659.69 | 271 / 359 | 97% | 54.79 | 277 / 286 |
| prostate | 87% | 1487.62 | 212 / 245 | 83% | 17.74 | 416 / 502 |
| uterus | 71% | 865.78 | 120 / 170 | 86% | 57.85 | 395 / 459 |
| intestine | 47% | 1743.47 | 456 / 966 | 99% | 57.42 | 521 / 527 |
| esophagus | 46% | 3435.85 | 660 / 1445 | 99% | 92.98 | 182 / 183 |
| breast | 54% | 705.00 | 248 / 459 | 91% | 34.02 | 1018 / 1118 |
| kidney | 80% | 1120.67 | 71 / 89 | 60% | 22.34 | 545 / 901 |
| bladder | 43% | 723.62 | 9 / 21 | 94% | 48.66 | 476 / 504 |
| skin | 95% | 4457.86 | 1721 / 1809 | 26% | 16.39 | 122 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 73.24 | 43 / 45 |
| ovary | 1% | 7.50 | 2 / 180 | 91% | 28.97 | 390 / 430 |
| adipose | 28% | 269.90 | 335 / 1204 | 0% | 0 | 0 / 0 |
| liver | 1% | 9.54 | 2 / 226 | 14% | 4.64 | 55 / 406 |
| adrenal gland | 3% | 15.86 | 7 / 258 | 10% | 3.14 | 23 / 230 |
| peripheral blood | 12% | 114.20 | 113 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 12% | 88.76 | 158 / 1335 | 0% | 0 | 0 / 0 |
| brain | 1% | 11.00 | 34 / 2642 | 9% | 1.44 | 64 / 705 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.29 | 1 / 29 |
| heart | 2% | 10.80 | 15 / 861 | 0% | 0 | 0 / 0 |
| spleen | 1% | 5.94 | 3 / 241 | 0% | 0 | 0 / 0 |
| muscle | 1% | 5.79 | 8 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CDCP1 |
| Protein name | CUB domain-containing protein 1 (Membrane glycoprotein gp140) (Subtractive immunization M plus HEp3-associated 135 kDa protein) (SIMA135) (Transmembrane and associated with src kinases) (CD antigen CD318) CUB domain-containing protein 1 |
| Synonyms | UNQ2486/PRO5773 TRASK |
| Description | FUNCTION: May be involved in cell adhesion and cell matrix association. May play a role in the regulation of anchorage versus migration or proliferation versus differentiation via its phosphorylation. May be a novel marker for leukemia diagnosis and for immature hematopoietic stem cell subsets. Belongs to the tetraspanin web involved in tumor progression and metastasis. . |
| Accessions | Q9H5V8 A0A172Q398 ENST00000296129.6 [Q9H5V8-1] ENST00000425231.2 [Q9H5V8-3] |
